Please wait a minute...
Frontiers of Chemical Science and Engineering

ISSN 2095-0179

ISSN 2095-0187(Online)

CN 11-5981/TQ

Postal Subscription Code 80-969

2018 Impact Factor: 2.809

Front Chem Eng Chin    2009, Vol. 3 Issue (3) : 305-309    https://doi.org/10.1007/s11705-009-0021-z
RESEARCH ARTICLE
Design, synthesis, and antiviral properties of 2-aryl-1H-benzimidazole-4-carboxamide derivatives
Xianjin LUO1(), Zhonglü ZHANG1, Yutian YANG1, Fei XUE1, Naiyun XIU2, Yuanbin SHE3()
1. School of Chemistry and Chemical Engineering, Shanghai Jiao Tong University, Shanghai 200240, China; 2. Schools of Life Science and Environmental Science, Shanghai Normal University, Shanghai 200234, China; 3. Institute of Green Chemistry and Fine Chemicals, Beijing University of Technology, Beijing 100022, China
 Download: PDF(113 KB)   HTML
 Export: BibTeX | EndNote | Reference Manager | ProCite | RefWorks
Abstract

A series of new benzimidazole derivatives were designed and synthesized. Their chemical structures were testified by 1H NMR, infrared spectroscopy (IR), mass spectrography (MS), and elemental analysis. Their potent antiviral properties indicated the prospect of new drugs. Compound 13, 16, 18, 19, 21, 22, and 23 were identified as novel antivirus with much better selective activity and inhibitory activity than the comparable ribavirin against Coxsackie virus B3 in VERO cells.

Keywords benzimidazole      coxsackie virus B3      antiviral properties     
Corresponding Author(s): LUO Xianjin,Email:luoxianjin@sjtu.edu.cn; SHE Yuanbin,Email:sheyb@bjut.edu.cn   
Issue Date: 05 September 2009
 Cite this article:   
Xianjin LUO,Zhonglü ZHANG,Yutian YANG, et al. Design, synthesis, and antiviral properties of 2-aryl-1H-benzimidazole-4-carboxamide derivatives[J]. Front Chem Eng Chin, 2009, 3(3): 305-309.
 URL:  
https://academic.hep.com.cn/fcse/EN/10.1007/s11705-009-0021-z
https://academic.hep.com.cn/fcse/EN/Y2009/V3/I3/305
Fig.1  General structure of synthesized compounds
Fig.2  Reagents and conditions: (a) NH(aq), 70°C; (b) KOH, Br, HO, 80°C; (c) NaOH, CHOH, Ranney Ni, NH×HO, reflux
compoundyield /%compoundyield /%
684.61770.1
780.51879.6
879.31982.1
988.22073.3
1086.72187.5
1187.92274.2
1253.12372.1
1351.32475.9
1464.12572.1
1561.32670.3
1668.02777.5
Tab.1  Yields of compounds -
Fig.3  Reagents and conditions: (d) CHOH, Cu(AcO), reflux, then NaS; (e) CHOH, KFe(CN), reflux; (f) SOCl, reflux; (g) RNH, r.t
compoundR1R2TC50 /(μg·mL-1)a)IC50 /(μg·mL-1)b)SIc)
1264.1515.904
1364.155.3012.1
1432.0710.693
1521.387.123
168.011.067.5
1727.77>9.25
RBV353.55
Tab.2  Activity of benzimidazole derivatives against Coxsackie virus B in VERO cells
compoundR1R2TC50 /(μg·mL-1)a)IC50 /(μg·mL-1)b)SIc)
168.011.067.5
1727.77>9.25
1815.330.5428.3
1937.03.2311.4
2012.3NAd)
2121.381.7612.1
2255.61.4338.8
2310.741.179.17
2415.643.854.06
25-CH2CH2OH160.237.04.32
26-CH2CH2OH192.425.597.51
27-CH2CH2OH140.6NA
RBV353.55
Tab.3  Activity of benzimidazole derivatives against Coxsackie virus B in VERO cells
1 Cheng J, Xie J T, Luo X J. Synthesis and antiviral activity against Coxsackie virus B3 of some novel benzimidazole derivatives. Bioorg Med Chem Lett , 2005, 15: 267-269
doi: 10.1016/j.bmcl.2004.10.087
2 Kristjan G, Richard S P, Aurora R L D. Preparation of (quinolinylaminoalkyl)-benzimidazole derivatives as chemokine receptor ligands with anti-HIV activity. WO2006023400
3 White A W, Almassy T, Calvert A H, Crutin N J, Griffin R J, Hostomsky Z, Maegley K, Newell D R, Srinivasan S, Golding B T. Resistance-modifying agents. 9. Synthesis and biological properties of benzimidazole inhibitors of the DNA repair enzyme poly(ADP-ribose) polymerase. J Med Chem , 2000, 43: 4084-4097
doi: 10.1021/jm000950v
4 Garuti L, Roberti M, Cermelli C. Synthesis and antiviral activity of some N-(benzenesulphonyl)-benzimidazoles. Bioorg Med Chem Lett , 1999, 9: 2525-2530
doi: 10.1016/S0960-894X(99)00429-1
5 Garuti L, Roberti M, Clercq E D. Synthesis and antiviral/antiproliferative activity of some N-sulphonyl-benzimidazoles. Bioorg Med Chem Lett , 2002, 12: 2707-2710
doi: 10.1016/S0960-894X(02)00535-8
6 Gilbert B E, Knight V. Biochemistry and clinical applications of ribavirin. Agents Chemother , 1986, 30: 201-205
7 Chapman E, Stephen H J. Preparation of phthalamic acids and their conversion into anthranilic acids. Chem Soc , 1925, 127: 1791-1797
8 Barkalow J H, Breting J, Gaede B J, Haight A R, Henry R, Kotecki B, Mei J, Pearl K B, Tedrow J S, Viswanath S K. Process Development for ABT-472, a Benzimidazole PARP Inhibitor. Organic Process Research and Development , 2007, 11: 693-698
doi: 10.1021/op7000194
9 William A D, Gordon W R, Bruce C B. Potential antitumor agents. 59. Structure-activity relationships for 2-phenylbenzimidazole-4-carboxamides, a new class of “minimal” DNA-intercalating agents which may not act via topoisomerase II. J Med Chem , 1990, 33: 814-819
doi: 10.1021/jm00164a054
[1] Yongli WANG, Shuyuan MA, Xiaodong Lü, Chuang XIE. Control of the agglomeration of crystals in the reactive crystallization of 5-(difluoromethoxy)-2-mercapto-1H-benzimidazole[J]. Front Chem Sci Eng, 2012, 6(4): 423-431.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed